| |
|
|
Acted for initial purchasers led by J.P. Morgan and TD Securities in connection with Air Canada's US$1.1 billion private placement offering of secured notes. The offering consisted of US$600 million of first-lien secured notes, CDN$300 million of Canadian dollar-denominated first-lien secured notes and US$200 million of second-lien secured notes. |
|
2010 |
|
| |
|
|
Acted for CDP Financial Inc., a wholly-owned subsidiary of Caisse de dépôt et placement du Québec in an offering of E750 million principal amount of 3.50% guaranteed notes due June 2020. |
|
2010 |
|
| |
|
|
Acted for CDP Financial Inc., a wholly-owned subsidiary of the Caisse de dépôt et placement du Québec in an offering of $2 billion of senior notes, comprised of $1 billion of FRN (floating rate notes) senior notes due 2015 and $1 billion of 4.60% senior notes due 2020. |
|
2010 |
|
| |
|
|
Acted for Adaltis Inc. in proceedings under the Companies' Creditors Arrangement Act and subsequent bankruptcy proceedings. |
|
2009 |
|
| |
|
|
Acted for CDP Financial Inc., a wholly-owned subsidiary of the Caisse de dépôt et placement du Québec, in connection with an offering of US$5 billion of senior notes in the United States. This offering is the largest non-government guaranteed offering by any Canadian issuer in US dollars to date. |
|
2009 |
|
| |
|
|
Acted for Onex Corporation and Celestica Inc. in the $113.3 million sale by Onex and certain of its affiliates of 11 million Celestica subordinate voting shares to a syndicate of underwriters led by the CIBC World Markets Inc. |
|
2009 |
|
| |
|
|
Acted for Genuity Capital Markets and a syndicate of underwriters in connection with a bought deal offering by Air Canada of units comprised of shares and warrants for aggregate gross proceeds of $260 million. |
|
2009 |
|
| |
|
|
Acted for Ernst & Young Inc., a Court-appointed Monitor, in connection with the restructuring of Quebecor World Inc. (now known as World Color Press Inc.) and 53 of its subsidiaries in excess of US$2.8 billion of liabilities and emerged from protection under the Companies' Creditors Arrangement Act and Chapter 11 of the U.S. Bankruptcy Code pursuant to Plans of Reorganization approved by creditors and courts in both countries. |
|
2008 |
|
| |
|
|
Acted for Adaltis Inc. in its $20 million private placement of 10% secured convertible notes due 2013. |
|
2008 |
|
| |
|
|
Acted for Adaltis Inc. in its $12.6 million rights offering for common shares. |
|
2008 |
|
| |
|
|
Acted for Pixman Nomadic Media Inc., a corporation listed on the TSX Venture Exchange, completed a private placement and issued 8,333,333 common shares for aggregate gross proceeds of approximately $1 million. |
|
2008 |
|
| |
|
|
Acted for AbitibiBowater Inc. in the sale of its Snowflake, Arizona mill to Catalyst Paper Corporation in a transaction valued at US$161 million. |
|
2008 |
|
| |
|
|
Acted for BCE Inc. in the sale of its subsidiary Telesat Canada to Public Sector Pension Investment Board and Loral Space & Communications Inc. in a transaction valued at $3.42 billion. |
|
2007 |
|
| |
|
|
Acted for Adaltis Inc. in connection with its $31 million private placement of units consisting of common shares and share purchase warrants. |
|
2007 |
|
| |
|
|
Acted for Abitibi-Consolidated Inc. in its merger of equals with Bowater Incorporated to create a company with a combined enterprise value of US$8 billion. |
|
2007 |
|
| |
|
|
Acted for MethylGene Inc. in a $20.1 million bought deal public offering of common shares. |
|
2007 |
|
| |
|
|
Acted for MethylGene Inc. in connection with its $21.3 million private placement of units consisting of common shares and share purchase warrants. |
|
2006 |
|
| |
|
|
Acted for Pixman Corporation in regard to the reverse takeover by Pixman Capital Inc., a publicly traded company, of Pixman Corporation. The current shareholders of Pixman Corporation will sell their shares to Pixman Capital Inc. in exchange for shares in Pixman Capital Inc. |
|
2006 |
|
| |
|
|
Acted for Adaltis Inc. on its completion of a financing of unsecured convertible debentures. |
|
2006 |
|
| |
|
|
Acted for MethylGene Inc. in connection with the entering into of a Collaborative Research, Development and Commercialization Agreement for its histone deacetylase (HDAC) inhibitors with Pharmion Corporation in North America, Europe, the Middle East and certain other markets. This transaction was valued at up to US$272 million and was thought to be the largest early stage biotechnology pact in Canada. As part of the transaction, Pharmion subscribed for US$5 million of MethylGene common shares. |
|
2006 |
|
| |
|
|
Acted as counsel for a syndicate of banks in the US$2.5 billion credit financing offered to Novelis Inc. and for the initial purchasers in the US$1.4 billion issuance of senior notes, as part of Alcan Inc.'s spin-off of its aluminum rolled products business. |
|
2006 |
|
| |
|
|
Acted for Bell Canada in regard to its acquisition of Nexxlink Technologies Inc. shares in a transaction valued at $67 million. |
|
2005 |
|
| |
|
|
Acted for SS&C Technologies Inc. in its acquisition of Financial Models Company Inc. in a transaction valued at approximately $207 million. |
|
2005 |
|
| |
|
|
Acted for Citigroup Global Markets Inc. and a syndicate of banks in the US$1.8 billion spinoff of Novelis Inc. by Alcan Inc. |
|
2005 |
|
| |
|
|
Completion of a $15 million convertible note financing with ConjuChem Inc., a Montréal-based biotechnology company. Davies represented Baker Brothers. |
|
2004 |
|
| |
|
|
Acted for MethylGene Inc., a biopharmaceutical company seeking treatment for cancer and infectious diseases in its $21.6 million initial public offering of common shares, and a concurrent $1.4 million private placement of common shares.
|
|
2004 |
|
| |
|
|
Acted for BCE Inc. in regard to the sale of the controlling interest in BCE Emergis Inc. through the issuance of subscription receipts for gross proceeds of approximately $356 million. |
|
2004 |
|
| |
|
|
Acted for McWatters Mining Inc. in connection with the plan of arrangement and reorganization under the Companies' Creditors Arrangement Act (Canada) and the Companies Act (Quebec), including a $47.4 million investment of capital by Soquem Inc. and Soquémex Inc., Sodémex II, s.e.c., the Fonds de solidarité des travailleurs du Québec (FTQ), Investissement Québec and Economic Development of Canada. |
|
2004 |
|
| |
|
|
Acted for Adaltis Inc. in its $55 million initial public offering. |
|
2004 |
|
